Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
emtricitabine (emtriva) (1 trial)
tenofovir (viread) (1 trial)
Acquired Immunodeficiency Syndrome (Phase 4)
HIV Infections (Phase 4)
Immunologic Deficiency Syndromes (Phase 4)
Trials (1 total)
Trial APIs (2 total)